To compare the magnitude of ERK activation to the magnitude of inhibition of BRAF-mutant melanoma cells, cell viability of A375 cells following BRAFi treatment was measured in parallel (Figure 1a–1d, Table 1). This evidence concerns the gene MAPK1 and melanoma.